Information de reference pour ce titreAccession Number: | 00002953-200202000-00035.
|
Author: | Bossone, Eduardo MD, PhD, FCCP; Paciocco, Giuseppe MD, FCCP; Iarussi, Diana MD; Agretto, Angelo MD, FCCP; Iacono, Aldo MD; Gillespie, Brenda W. PhD; Rubenfire, Melvyn MD, FCCP
|
Institution: | *From the Division of Cardiology, Department of Internal Medicine (Drs. Bossone, Paciocco, and Rubenfire), and Center for Statistical Consultation and Research (Dr. Gillespie), University of Michigan, Ann Arbor, MI; and Dipartimento di Cardiologia (Drs. Iarussi, Agretto, and Iacono), II Universita' degli Studi, Napoli, Italy.
|
Title: | The Prognostic Role of the ECG in Primary Pulmonary Hypertension*.[Article]
|
Source: | Chest. 121(2):513-518, February 2002.
|
Abstract: | Background/rationale: Doppler echocardiography and invasive hemodynamic parameters reflective of right ventricular failure are associated with a poor prognosis in patients with primary pulmonary hypertension (PPH). The aims of the present study were to examine whether ECG features in patients with PPH are associated with a decrease in survival, and to determine the value of the ECG in risk stratification.
Methods/results: We analyzed the ECG, New York Heart Association (NYHA) class, and hemodynamic parameters in 51 untreated patients with PPH (88% women; mean age, 41.7 years; 79% NYHA classes III and IV) evaluated between 1992 and 1998. Subsequent treatment included epoprostenol in 37 patients, calcium channel blockers in 10 patients, epoprostenol and atrial septostomy in 2 patients, and lung transplant in 3 patients. As of 1999, 16 patients had died. Based on Kaplan-Meier estimates, median survival was > 6.5 years and estimated survival at 1 year, 3 years, and 5 years was 86%, 71%, and 57%, respectively. Significant predictors of decreased survival by Cox regression analysis include pulmonary vascular resistance (PVR; hazard ratio [HR], 1.11 per Wood unit), cardiac index (HR, 0.22 per L/min/m2), p wave amplitude in lead II (HR, 3.06 per mm), p >= 0.25 mV in lead II (HR, 2.77), qR in V1 (HR, 3.55), and World Health Organization criteria for right ventricular hypertrophy (HR, 4.26). After controlling for PVR, the HRs attributable to the ECG criteria were only slightly diminished. NYHA class and pulmonary artery pressures did not correlate with a decrease in survival.
Conclusions: ECG parameters reflective of physiologic and anatomic abnormalities in the right ventricle are associated with decreased survival in patients with PPH, and may be useful for deciding therapeutic choices including the timing for lung transplantation listing.
Copyright (C) 2002 by the American College of Chest Physicians
|
Author Keywords: | ECG; primary pulmonary hypertension; prognosis.
|
References: | 1 Rich S, Dantzker D, Ayres S, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216-223
2 Rubin L. Current concepts: primary pulmonary hypertension. N Engl J Med 1997; 336:111-117
3 Rich S, Kaufmann E, Levy P. Effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81
4 Barst R, Rubin L, Long W, et al. Comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334:296-302
5 Higenbottam T, Butt A, McMahon A, et al. Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. Heart 1998; 80:151-155
6 Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998; 32:297-304
7 Hosenpud J, Bennett L, Keck B, et al. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report-1998. J Heart Lung Transplant 1998; 17:656-668
8 Glanville A, Burke C, Theodore J, et al. Primary pulmonary hypertension: length of survival in patients referred for heart-lung transplantation. Chest 1987; 91:675-681
9 Nootens M, Freels S, Kaufmann E, et al. Timing of single lung transplantation for primary pulmonary hypertension. J Heart Lung Transplant 1994; 13:276-281
10 Conte J, Gaine S, Orens J, et al. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. J Heart Lung Transplant 1998; 17:679-685
11 D'Alonzo G, Barst R, Ayres S, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-349
12 Eysmann S, Palevsky H, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80:353-360
13 Rich S, Brundage B, Levy P. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 1985; 71:1191-1196
14 Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161:487-492
15 Paciocco G, Martinez F, Bossone G, et al. Oxygen desaturation during the six-minute walk is associated with mortality in untreated primary pulmonary hypertension. Eur Respir J 2001; 17:1-6
16 Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998; 31:383-390
17 Kanemoto N. Electrocardiogram in primary pulmonary hypertension. Eur Respir J 1981; 12:181-193
18 Rozkovec A, Montanes P, Oakley C. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986; 55:449-458
19 Schrader B, Inbar S, Kaufmann L, et al. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension. J Am Coll Cardiol 1992; 19:1060-1064
20 Ricciardi M, Knight B, Martinez F, et al. Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine. J Am Coll Cardiol 1998; 32:1068-1073
21 Rich S, Kaufmann E. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing. J Am Coll Cardiol 1991; 18:1323-1327
22 Lehtonen J, Sutinen S, Ikaheimo M, et al. Electrocardiographic criteria for the diagnosis of right ventricular hypertrophy verified at autopsy. Chest 1988; 93:839-842
23 Goldman M. Principles of clinical electrocardiography. 12th ed. Los Altos. CA: Lange Medical Publications, 1986
24 Schamroth L. Introduction to electrocardiography. 7th ed. London, UK: Blackwell Scientific Publications, 1990
25 Roman G, Walsh T, Massie E. Right ventricular hypertrophy: correlation of electrocardiographic and anatomic findings. Am J Cardiol 1961; 7:481-487
26 Rich S, Seidlitz M, Dodin E, et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998; 114:787-792
27 Kanemoto N. Electrocardiogram in primary pulmonary hypertension-with special reference to prognosis. Tokai J Exp Clin Med 1987; 12:173-179
28 World Health Organization. Chronic cor pulmonale: report of an expert committee. Circulation 1953; 27:594-615
29 Anselmi G, Munoz-Armas S, Salazar A, et al. Electrocardiographic patterns of right atrial overloading in some congenital heart conditions. Am J Cardiol 1968; 21:628-638
30 Sodi-Pallares D, Bisteni A, Hermann G. Some views on the significance of qR and QR type complexes in right precordial leads in the absence of myocardial infarction. Am Heart J 1952; 43:716-734
31 Kanemoto N. Electrocardiographic and hemodynamic correlations in primary pulmonary hypertension. Angiology 1988; 39:781-787
32 Bossone E, Duong-Wanger T, Paciocco G, et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr 1999; 12:655-662
|
Language: | English.
|
Document Type: | Clinical Investigations: Cardiology.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0012-3692
|
NLM Journal Code: | 0231335, d1c
|
Annotation(s) | |
|
|